The Annual Meeting of the European Heart Rhythm Association (EHRA 2022)

Which DOAC is safest to use in AF patients on dronedarone therapy?

Stephen Padilla, 20220502120000

Among patients on concomitant treatment with direct oral anticoagulants (DOACs) and dronedarone, no difference is seen in survival free from the composite endpoint (ie, clinically relevant bleeding, thromboembolic event, and all-cause death) and from clinically relevant bleeding between groups of coadministration, according to a study.

Bipolar ablation of heart arrhythmia safe, effective in lieu of failed unipolar approach

Stephen Padilla, 20220429120000

Use of bipolar radiofrequency ablation (BRFA) is both safe and effective in selected patients who have failed at least one standard unipolar approach, suggest the results of a systematic review and meta-analysis. However, the quality of the supporting evidence is low.

Sports-related sudden cardiac deaths: Why do men have it worse?

Audrey Abella, 20220428100000

When it comes to sports-related* sudden cardiac death (SCD) rates, men appear to have it worse than women, according to data presented at EHRA 2022.

Rhythm control should be started earlier in women vs men

Jairia Dela Cruz, 20220427140000

Early initiation of rhythm control for atrial fibrillation (AF) appears to be favourable, but women should start rhythm control treatment earlier than men to get the best possible outcomes, according to a study presented at the annual meeting of the European Heart Rhythm Association (EHRA).

RESET-CRT questions the need of defibrillation in CRT for HF

Putting heart to rhythm: ICD better than pacemaker, really?

Pearl Toh, 20220426150100

Pacemaker is not inferior to implantable cardiac defibrillator (ICD) device in terms of survival for heart failure (HF), according to the RESET-CRT study presented at EHRA 2022 — thus raising the question on the need of defibrillation in CRT for these patients.

Prolonged QTc in hospitalized COVID-19 patients tied to increased mortality risk

Roshini Claire Anthony, 20220425150001

Prolonged corrected QT interval (QTc), as determined via electrocardiogram (ECG), may indicate an elevated risk of myocardial injury and death in patients hospitalized for COVID-19, according to a prospective study from Israel presented at EHRA 2022.

Can we predict sudden cardiac arrests in the general population?

Audrey Abella, 20220422100000

The quest for a personalized risk model that can foretell sudden cardiac arrests (SCAs) in the general population remains, as the ESCAPE-NET* research project falls short in their pursuit to identify such a model that can predict SCA risk in this population.

AF affects one-third of patients after cryptogenic stroke, TIA

Roshini Claire Anthony, 20220419180001

Almost 30 percent of patients who experience a cryptogenic stroke or transient ischaemic attack (TIA) go on to develop atrial fibrillation (AF), most of them asymptomatic, according to results of the NOR-FIB* study presented at EHRA 2022.

GPs rank routine screening for AF as crucial as for common cancers

GPs rank routine screening for AF as crucial as for cancers

Pearl Toh, 20220415150100

Screening for atrial fibrillation (AF) is considered to be as important as for common cancers and should be incorporated into other healthcare programmes such as flu vaccination and cancer screening programmes, based on data from the AFFECT-EU survey of GPs that was presented at EHRA 2022.

Elevated BMI may up recurrent AF risk

Roshini Claire Anthony, 20220413180001

Among patients who had previously undergone ablation for atrial fibrillation (AF), the risk of recurrent AF increased with rising body mass index (BMI), according to a study from Denmark presented at EHRA 2022.